NasdaqCM - Nasdaq Real Time Price USD

The Joint Corp. (JYNT)

Compare
10.33
+0.30
+(2.99%)
At close: January 13 at 4:00:01 PM EST
10.54
+0.21
+(2.03%)
Pre-Market: 7:07:01 AM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
120,795.62
117,696.36
101,252.31
80,011.01
58,682.98
Cost of Revenue
11,238.28
10,546.56
9,171.06
7,665.14
6,507.47
Gross Profit
109,557.34
107,149.80
92,081.25
72,345.88
52,175.51
Operating Expense
108,177.81
106,590.28
90,842.78
66,193.12
46,734.70
Operating Income
1,379.53
559.52
1,238.47
6,152.75
5,440.81
Other Income Expense
-6,918.19
1,079.24
-543.32
-96.67
-28.16
Pretax Income
-5,538.66
1,638.76
695.15
6,056.09
5,412.65
Tax Provision
11,317.50
11,390.95
68.45
-1,508.96
-7,754.66
Net Income Common Stockholders
-16,856.16
-9,752.20
626.71
7,565.05
13,167.31
Diluted NI Available to Com Stockholders
-16,856.16
-9,752.20
626.71
7,565.05
13,167.31
Basic EPS
-1.14
-0.66
0.08
0.50
0.94
Diluted EPS
-1.14
-0.66
0.08
0.48
0.90
Basic Average Shares
14,866.24
14,688.12
14,488.31
14,319.45
14,003.71
Diluted Average Shares
15,090.22
14,935.22
14,868.09
14,935.58
14,582.88
Total Operating Income as Reported
-5,740.97
-2,073.09
828.25
6,125.97
5,492.13
Total Expenses
119,416.09
117,136.84
100,013.84
73,858.26
53,242.17
Net Income from Continuing & Discontinued Operation
-16,856.16
-9,752.20
626.71
7,565.05
13,167.31
Normalized Income
-11,230.96
-7,672.44
996.72
7,584.60
13,129.85
EBIT
1,379.53
559.52
1,238.47
6,152.75
5,440.81
EBITDA
7,235.16
9,141.72
7,885.09
10,074.64
8,175.27
Reconciled Cost of Revenue
11,238.28
10,546.56
9,171.06
7,665.14
6,507.47
Reconciled Depreciation
5,855.63
8,582.20
6,646.62
3,921.89
2,734.46
Net Income from Continuing Operation Net Minority Interest
-16,856.16
-9,752.20
626.71
7,565.05
13,167.31
Total Unusual Items Excluding Goodwill
-7,120.51
-2,632.60
-410.22
-26.79
51.32
Total Unusual Items
-7,120.51
-2,632.60
-410.22
-26.79
51.32
Normalized EBITDA
14,355.67
11,774.32
8,295.31
10,101.43
8,123.95
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-1,495.31
-552.85
-40.20
-7.23
13.86
12/31/2020 - 11/11/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CCEL Cryo-Cell International, Inc.
7.25
+2.11%
 
SGRY Surgery Partners, Inc.
21.16
+2.47%
 
FME.DE Fresenius Medical Care AG
43.53
+0.23%
 
ASTH Astrana Health, Inc.
30.28
+2.71%
 
EHAB Enhabit, Inc.
7.77
+2.24%
 
BACK IMAC Holdings, Inc.
1.2100
-3.97%
 
TOI The Oncology Institute, Inc.
0.3117
+3.31%
 
CHE Chemed Corporation
530.11
+1.58%
 
EHC Encompass Health Corporation
92.56
+1.66%
 
MD Pediatrix Medical Group, Inc.
13.31
+6.99%